Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ANPEP | P15144 | 2/20 | 0.44 |
| ▸ | LAP3 | P28838 | 2/20 | 0.44 |
| ▸ | SRC | P12931 | 1/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | MMP14 | P50281 | 1/20 | 0.37 |
| ▸ | CA9 | Q16790 | 1/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ACP3 | P15309 | 1/20 | 0.36 |
| ▸ | ELANE | P08246 | 1/20 | 0.35 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.35 |
| ▸ | BTN3A1 | O00481 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18831779 | 0.84 | ANPEP (0.40) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL23542051 | 0.84 | ANPEP (0.40) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL18892876 | 0.79 | MEN1 (0.41) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL22817527 | 0.75 | SRC (0.48) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL22817526 | 0.75 | SRC (0.48) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL29186011 | 0.74 | SRC (0.55) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL12202898 | 0.73 | BTN3A1 (0.56) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL17479414 | 0.73 | BTN3A1 (0.56) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL12202875 | 0.73 | BTN3A1 (0.56) | ANPEPLAP3SRCMEN1KMT2A | |
| SCHEMBL12202882 | 0.73 | BTN3A1 (0.56) | ANPEPLAP3SRCMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20190276481-A1 | Liver Prodrugs of Mitochondrial Proton Ionophores | NEUROVIVE PHARMACEUTICAL AB (SE) | 2019-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190276481-A1 | Liver Prodrugs of Mitochondrial Proton Ionophores | GLS2, CYP27A1, SLC25A21 | ANPEP 1563/4885LAP3 913/4885SRC 4722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.